Business Description
TYK Medicines Inc. is a China-based drug development company focused on creating new treatments for cancer and metabolic diseases such as diabetes and obesity. Founded in 2017 and headquartered in Huzhou, the company is advancing a broad pipeline of oral therapies targeting various forms of solid tumors, including lung and breast cancer. Its lead drug candidate aims to address brain complications arising from a common type of lung cancer, while several other compounds are being developed to block the biological signals that allow cancer cells to grow and spread.
